0.00
100.00%
-64.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALPN Giù?
Forum
Previsione
Frazionamento azionario
Alpine Immune Sciences Inc Borsa (ALPN) Ultime notizie
MyMyasthenia Gravis Clinical Trial Analysis, 2024 Updates | - openPR
Big Drugmakers Are Clinching Smaller Deals - The Wall Street Journal
Big Drugmakers Are Clinching Smaller Deals - Yahoo Finance
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex - MSN
Vertex Lifts Revenue Outlook on Growth of Cystic Fibrosis Drugs - Bloomberg
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments - Yahoo Finance
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune - MSN
Vertex enters into a definitive agreement to acquire Alpine Immune Sciences - World Business Outlook
Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are still up 200% over 3 years - Yahoo New Zealand News
Fastest Growing Public Companies in Washington State - The Business Journals
Vertex Pharmaceuticals reports $4.4 billion R&D expense post-acquisition - Investing.com
Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are ... - Yahoo New Zealand News
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year? - Yahoo Lifestyle Singapore
Esperion Therapeutics (ESPR) Moves 6.5% Higher: Will This Strength Last? - Yahoo Lifestyle Singapore
Here's Why You Should Invest in Alpine (ALPN) Stock Now - Yahoo Lifestyle UK
Alpine Immune Sciences (NASDAQ:ALPN) jumps 12% this week, taking three-year gains to 96% - Yahoo Sport Australia
Biopharma index outpaces market benchmarks with an 8% rise - BioWorld Online
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Sport Australia
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Movies UK
Alpine Immune Sciences And Abbvie Announce Option And License Agreement For Development And Commercialization Of ALPN-101 - Reuters
Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market - BioSpace
Rafferty Asset Management LLC Purchases Shares of 80162 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Given Consensus Rating of “Hold” by Brokerages - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Is a Surprise Coming for Alpine Immune Sciences (ALPN) This Earnings Season? - Yahoo Movies UK
Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last? - Yahoo Singapore News
Swiss National Bank Grows Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Trexquant Investment LP Purchases 25202 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune (ALPN) Stock Up 19% MTD, Will the Uptick Continue? - Yahoo Movies UK
Franklin Resources Inc. Acquires Shares of 1220333 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
BNP Paribas Financial Markets Has $2.04 Million Stock Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat
BNP Paribas Financial Markets Buys 93423 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Vertex Pharma's $4.9 billion takeover of Alpine Immune gives it access to a potential billion-dollar franchise, analyst says - MSN
Fenwick Represents Alpine Immune Sciences in its Acquisition by Vertex Pharmaceuticals - Fenwick & West LLP
How To Trade (ALPN) - Stock Traders Daily
Jump Financial LLC Takes Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat
Alpine Immune jumps on report of takeover interest - MSN
Jump Financial LLC Invests $1.06 Million in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Acquired by New York State Common Retirement Fund - Defense World
Wedbush Reiterates "Neutral" Rating for Alpine Immune Sciences (NASDAQ:ALPN) - MarketBeat
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
What 11 Analyst Ratings Have To Say About Alpine Immune SciencesAlpine Immune Sciences (NASDAQ:ALPN) - Benzinga
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences - Quantisnow
Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 12-Month High at $64.96 - MarketBeat
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Significant Drop in Short Interest - MarketBeat
Alpine Immune Sciences, Inc. (ALPN) Earnings Expected to Grow: What to Know Ahead of Q3 Release - Yahoo Movies UK
Alpine Immune Sciences (NASDAQ:ALPN) Sees Strong Trading Volume - Defense World
Strength Seen in Alpine Immune Sciences, Inc. (ALPN): Can Its 7.5% Jump Turn into More Strength? - Yahoo Lifestyle UK
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ... - Yahoo Finance
Alpine Immune stock ticks higher as HSR waiting period for Vertex Pharma deal expires - Seeking Alpha
Alpine Immune Sciences Communicates Key Updates RegularlyTipRanks.com - TipRanks
Alpine Immune Sciences Reports First Quarter 2024 Financial Results - Business Wire
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Position Cut by Vivo Capital LLC - MarketBeat
Alpine Immune Sciences (NASDAQ:ALPN) Sets New 52-Week High at $64.72 - MarketBeat
Alpine Immune Sciences (NASDAQ:ALPN) shareholders have earned a 20% CAGR over the last five years - Yahoo Movies UK
Zevra Therapeutics (ZVRA) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
Zurcher Kantonalbank Zurich Cantonalbank Makes New Investment in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Great news for Alpine Immune Sciences, Inc. (NASDAQ:ALPN): Insiders acquired stock in large numbers last year - Yahoo Sport Australia
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Movies Canada
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales - Zacks Investment Research
Here's Why You Should Invest in Alpine (ALPN) Stock Now - Yahoo News UK
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):